Aclaris Therapeutics
ACRS
ACRS
46 hedge funds and large institutions have $284M invested in Aclaris Therapeutics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
46
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.8M | |
| 2 | +$4.68M | |
| 3 | +$4.62M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.93M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.62M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$1.65M | |
| 3 | -$1.19M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$341K |
| 5 |
Citigroup
New York
|
-$138K |